Reconfigurable MRI technology for safe and high-resolution imaging of deep brain stimulation at 3T
Project Number5R01EB030324-04
Former Number1R01EB030324-01
Contact PI/Project LeaderGOLESTANI RAD, LALEH
Awardee OrganizationNORTHWESTERN UNIVERSITY AT CHICAGO
Description
Abstract Text
Project Summary
Deep brain stimulation (DBS) is a neurosurgical procedure that involves implanting electrodes into specific areas
within the brain and delivering constant or intermittent electric pulses from an implanted pulse generator (IPG)
to modulate neural function. DBS is the gold standard treatment for Parkinson’s disease, and has shown promise
in treating other disorders, most notably chronic pain, epilepsy, major depression, and Alzheimer’s disease.
Magnetic resonance imaging (MRI) is extremely useful in patients with DBS implants, as it can provide
information on precise location of implanted electrodes and functional response to stimulation. Unfortunately,
the interaction of radiofrequency (RF) fields generated by MRI scanners with the leads of DBS devices can
trigger potentially fatal RF heating within the tissue. This means that current MRI technology is inaccessible to
most patients with DBS implants, presenting a significant barrier to progress in the field of DBS therapeutics.
This project seeks to develop novel MRI methodologies alongside DBS implantation techniques that together
will make cutting-edge MRI technology fully compatible with implanted DBS devices. Here, this two-pronged
approach takes the form of (1) building on our recently introduced concept of reconfigurable MRI technology;
and (2) establishing surgical guidelines specific to DBS device implantation.
Reconfigurable MRI technology is based on the idea that through innovative engineering we can control local
electric fields generated by MR on a patient-by-patient basis, thus avoiding interactions with an implanted device,
wherever it happens to be. Part and parcel with engineering-based solutions, we recognize the importance of
DBS device lead placement in optimizing the success of the reconfigurable MRI approach. Although RF heating
depends exquisitely on lead-trajectory, surgical guidelines are completely silent as to how to best place the
extracranial portion of the leads. This in turn leads to arbitrary (and highly variable) lead positioning, which can
make RF heating unpredictable even when using reconfigurable technology. Thus, we propose work to develop
and validate novel MR technology (Aim 1), intra-surgical implantation strategies (Aim 2), and simulation-based,
patient-specific approaches to defining safe imaging parameters (Aim 3). Together, these efforts will eliminate
RF heating, reduce image artifact, and support the use of next generation MRI in patients with DBS implants.
Our team includes experts in MRI hardware development and instrumentation, MRI computational modeling and
safety assessment, FDA regulatory scientists, DBS clinical management and neurosurgery, as well as
collaborators from DBS device industry. If successful, we will bring state-of-the-art 3T MRI to DBS patients in
its full capacity. This will allow for methodical analysis of DBS parameters/targets in emerging applications,
improve our understanding of DBS in existing indications, and bring standard-of-care imaging to patients with
existing DBS implants.
Public Health Relevance Statement
Project Narrative
Patients with deep brain stimulation implants can highly benefit from magnetic resonance imaging (MRI) exams, but MRI
is not accessible to these patients because of safety risks due to radiofrequency heating of implants. In this project we
will develop novel MRI hardware and DBS lead management strategies that eliminate RF heating and bring high
resolution MRI accessible to DBS patients.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
005436803
UEI
KG76WYENL5K1
Project Start Date
15-July-2021
Project End Date
31-March-2026
Budget Start Date
01-April-2024
Budget End Date
31-March-2026
Project Funding Information for 2024
Total Funding
$507,738
Direct Costs
$345,611
Indirect Costs
$162,127
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$507,738
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB030324-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB030324-04
Patents
No Patents information available for 5R01EB030324-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB030324-04
Clinical Studies
No Clinical Studies information available for 5R01EB030324-04
News and More
Related News Releases
No news release information available for 5R01EB030324-04
History
No Historical information available for 5R01EB030324-04
Similar Projects
No Similar Projects information available for 5R01EB030324-04